The Texas Department of Public Safety (DPS) has conditionally licensed nine companies in Phase 1 of its medical cannabis program expansion, with three more expected in Phase 2, significantly boosting the number of active producers currently serving over 127,000 registered patients. These new licensees must pass due diligence and become operational within 24 months, adhering to the program's restriction of low-THC products (1 gram or less per serving) and prohibition of smokable cannabis.

Texas Chooses 9 Medical Cannabis Companies for Program’s Expansion

Dec 4, 2025

TG Branfalt

Ganjapreneur

The Texas Department of Public Safety (DPS) has chosen nine companies for
conditional medical cannabis licenses as part of its program expansion. The
companies’ selection is part of Phase 1 of its medical cannabis program
expansions, with three more conditional licenses expected to be awarded
during Phase 2, which ends April 1.

The companies selected during Phase 1 include:

- Dilatso, LLC
- Lone Star Bioscience, Inc
- Lonestar Compassionate Care Group, LLC
- PC TX OPCP LLC (PharmaCann)
- Story of Texas, LLC
- Texa OP (TexaRx)
- Texas Patient Access, LLC
- Trulieve TX, Inc
- Verano Texas, LLC

All of the organizations will undergo due diligence evaluations, including
previous disciplinary actions, financial suitability, litigation history,
and any other information as required by DPS. Once a license is finalized,
the licensee will have 24 months to become operational.

As of September, there were 127,206 registered medical cannabis patients in
the state, according to DPS data. There are currently just three active
licensed medical cannabis producers in the state: FLUENT (Cansortium),
Texas Original, and goodblend (Surterra Texas).

The state medical cannabis program only allows low-THC products with 1 gram
of THC or less per serving and does not allow any smokable cannabis.